These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7702782)
1. Evaluation of the thrombogenecity of microvascular prosthesis by in vivo microscopy. Kim YB; Reisch HP; Serafin D; Klitzman B J Korean Med Sci; 1994 Oct; 9(5):357-61. PubMed ID: 7702782 [TBL] [Abstract][Full Text] [Related]
3. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862 [TBL] [Abstract][Full Text] [Related]
4. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178 [TBL] [Abstract][Full Text] [Related]
5. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575 [TBL] [Abstract][Full Text] [Related]
6. Heparin bonding increases patency of long microvascular prostheses. Ritter EF; Fata MM; Rudner AM; Klitzman B Plast Reconstr Surg; 1998 Jan; 101(1):142-6. PubMed ID: 9427927 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716 [TBL] [Abstract][Full Text] [Related]
10. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921 [TBL] [Abstract][Full Text] [Related]
11. An alternative method for proximal placement of the heparin-coated tridodecylmethylammonium chloride (TDMAC) shunt. Wingard T; Donahoo JS; Williams GM Johns Hopkins Med J; 1979 Dec; 145(6):230-1. PubMed ID: 513430 [TBL] [Abstract][Full Text] [Related]
12. Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost. Greco RS; Kim HC; Donetz AP; Harvey RA Ann Vasc Surg; 1995 Mar; 9(2):140-5. PubMed ID: 7540408 [TBL] [Abstract][Full Text] [Related]
13. The effect of carbon coating and porosity on early patency of expanded polytetrafluoroethylene grafts: an experimental study. Akers DL; Du YH; Kempczinski RF J Vasc Surg; 1993 Jul; 18(1):10-5. PubMed ID: 8326650 [TBL] [Abstract][Full Text] [Related]
14. Reduction of bacterial adherence to catheter surface with heparin. Ruggieri MR; Hanno PM; Levin RM J Urol; 1987 Aug; 138(2):423-6. PubMed ID: 3298698 [TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. Lumsden AB; Morrissey NJ; J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929 [TBL] [Abstract][Full Text] [Related]
19. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model. Gosselin C; Ren D; Ellinger J; Greisler HP Am J Surg; 1995 Aug; 170(2):126-30. PubMed ID: 7543261 [TBL] [Abstract][Full Text] [Related]
20. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans. Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]